Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
2.2%
1w
6.0%
1m
10.6%
3m
26.9%
6m
39.7%
1y
8.4%
all
16.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 543 2.2%
538
758
Company Overview

Sales
1,179 Cr
Growth: 52.6%
Profit after Tax
352 Cr
Growth: -1.7%
Mid Cap
9,421 Cr
P/E: 26.9x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 1,179
Growth 52.6%
EBITDA 37.3%
P/S 8.1x
Dividend 0.2%
P/E 26.9x
Book Value ₹ 73.6
PEG Ratio 0.5x
ROE 30.2%
P/B 7.7x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)